GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Opus Genetics Inc (STU:R3X1) » Definitions » PB Ratio

Opus Genetics (STU:R3X1) PB Ratio : 0.71 (As of Mar. 14, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Opus Genetics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-03-14), Opus Genetics's share price is €0.839. Opus Genetics's Book Value per Share for the quarter that ended in Sep. 2024 was €1.18. Hence, Opus Genetics's PB Ratio of today is 0.71.

Good Sign:

Opus Genetics Inc stock PB Ratio (=0.71) is close to 5-year low of 0.71

The historical rank and industry rank for Opus Genetics's PB Ratio or its related term are showing as below:

STU:R3X1' s PB Ratio Range Over the Past 10 Years
Min: 0.71   Med: 2.17   Max: 4.86
Current: 0.71

During the past 5 years, Opus Genetics's highest PB Ratio was 4.86. The lowest was 0.71. And the median was 2.17.

STU:R3X1's PB Ratio is ranked better than
84.69% of 1280 companies
in the Biotechnology industry
Industry Median: 2.33 vs STU:R3X1: 0.71

During the past 12 months, Opus Genetics's average Book Value Per Share Growth Rate was -41.10% per year.

Back to Basics: PB Ratio


Opus Genetics PB Ratio Historical Data

The historical data trend for Opus Genetics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Opus Genetics PB Ratio Chart

Opus Genetics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
- - 2.97 1.38 1.42

Opus Genetics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.53 1.42 1.06 0.94 0.96

Competitive Comparison of Opus Genetics's PB Ratio

For the Biotechnology subindustry, Opus Genetics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Opus Genetics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Opus Genetics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Opus Genetics's PB Ratio falls into.



Opus Genetics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Opus Genetics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=0.839/1.18
=0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Opus Genetics  (STU:R3X1) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Opus Genetics PB Ratio Related Terms

Thank you for viewing the detailed overview of Opus Genetics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Opus Genetics Business Description

Traded in Other Exchanges
Address
37000 Grand River Avenue, Suite 120, Farmington Hills, MI, USA, 48335
Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA) and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

Opus Genetics Headlines

No Headlines